129 related articles for article (PubMed ID: 29212486)
61. Intravesical BCG instillation as a possible cause of acute and chronic kidney injury.
Tamzali Y; Jamme M; Bottet F; Gauthe M; Rondeau E; Pialoux G; Calin R
Infect Dis Now; 2021 Mar; 51(2):209-211. PubMed ID: 33007403
[No Abstract] [Full Text] [Related]
62. Reactive Arthritis following Bacillus Calmette-Guerin Therapy for Bladder Cancer: a Systematic Literature Review.
Abdelghani KB; Nacef L; Miladi S; Sellami M; Ouenniche K; Souabni L; Kassab S; Chekili S; Fazaa A; Laatar A
Curr Rheumatol Rep; 2021 Apr; 23(6):39. PubMed ID: 33913026
[TBL] [Abstract][Full Text] [Related]
63. Frequency of reactive arthritis, uveitis, and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy: A 20-year, two-centre retrospective study.
Taniguchi Y; Nishikawa H; Karashima T; Yoshinaga Y; Fujimoto S; Terada Y
Joint Bone Spine; 2017 Oct; 84(5):637-638. PubMed ID: 27825571
[No Abstract] [Full Text] [Related]
64. Malignancy diseases and kidneys: A nephrologist prospect and updated review.
Habas E; Akbar R; Farfar K; Arrayes N; Habas A; Rayani A; Alfitori G; Habas E; Magassabi Y; Ghazouani H; Aladab A; Elzouki AN
Medicine (Baltimore); 2023 Apr; 102(15):e33505. PubMed ID: 37058030
[TBL] [Abstract][Full Text] [Related]
65. Incidental discovery of a case of renal tuberculoma after intravesical BCG treatment.
Sikpa KH; Danjou P; Mahjoubi Z; Makke S; Bernard A; Chaabane C
Urol Case Rep; 2022 Nov; 45():102177. PubMed ID: 36033166
[TBL] [Abstract][Full Text] [Related]
66. Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease.
Chua JT; Argueta DA; DiPatrizio NV; Kovesdy CP; Vaziri ND; Kalantar-Zadeh K; Moradi H
Cannabis Cannabinoid Res; 2019; 4(1):10-20. PubMed ID: 31346545
[No Abstract] [Full Text] [Related]
67. Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice.
Unda-Urzaiz M; Cozar-Olmos JM; Miñana-Lopez B; Camarero-Jimenez J; Brugarolas-Rossello X; Zubiaur-Libano C; Ribal-Caparros MJ; Suarez-Charneco AJ; Rodriguez-Tesedo V; Chantada-Abal V; Ruiz-de-Leon C; Carrillo-George C; Carballido-Rodriguez J; Villacampa-Auba F;
Actas Urol Esp (Engl Ed); 2018 May; 42(4):238-248. PubMed ID: 29295749
[TBL] [Abstract][Full Text] [Related]
68. ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.
Campos MAG; Valois TO; Magalhães LE; Vasques LF; de Medeiros RG; Costa DMDN; Salgado Filho N; Nogueira RMDR; Neves PDMM; Silva GEB
Front Immunol; 2023; 14():1298622. PubMed ID: 38299140
[TBL] [Abstract][Full Text] [Related]
69. Haemophagocytic lymphohistiocytosis after intravesical BCG administration for bladder cancer presenting with multiorgan failure.
Liatsos GD; Manousopoulou G; Poulaki A; Iliaki A; Mariolis I; Vassilopoulos D
Access Microbiol; 2023; 5(9):. PubMed ID: 37841100
[TBL] [Abstract][Full Text] [Related]
70. Acute Kidney Injury in Cancer Immunotherapy Recipients.
Joseph A; Lafarge A; Azoulay E; Zafrani L
Cells; 2022 Dec; 11(24):. PubMed ID: 36552755
[TBL] [Abstract][Full Text] [Related]
71. Adverse Renal Effects of Anticancer Immunotherapy: A Review.
Borówka M; Łącki-Zynzeling S; Nicze M; Kozak S; Chudek J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077623
[TBL] [Abstract][Full Text] [Related]
72. Serum protein and electrolyte imbalances are associated with chemotherapy induced neutropenia.
Abbasi B; Hayat A; Lyons M; Gupta A; Gupta S
Heliyon; 2022 Jul; 8(7):e09949. PubMed ID: 35865973
[TBL] [Abstract][Full Text] [Related]
73. Acute Tubulointerstitial Nephritis in Clinical Oncology: A Comprehensive Review.
Martínez-Valenzuela L; Draibe J; Fulladosa X; Gomà M; Gómez F; Antón P; Cruzado JM; Torras J
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652638
[TBL] [Abstract][Full Text] [Related]
74. Acute renal failure due to interstitial nephritis after intravesical instillation of BCG.
Jose Manzanera Escribano M; Morales Ruiz E; Odriozola Grijalba M; Gutierrez Martínez E; Rodriguez Antolín A; Praga Terente M
Clin Exp Nephrol; 2007 Sep; 11(3):238-240. PubMed ID: 17891353
[TBL] [Abstract][Full Text] [Related]
75. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
[TBL] [Abstract][Full Text] [Related]
76. Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.
Marttila T; Järvinen R; Liukkonen T; Rintala E; Boström P; Seppänen M; Tammela T; Hellström P; Aaltomaa S; Leskinen M; Raitanen M; Kaasinen E;
Eur Urol; 2016 Aug; 70(2):341-7. PubMed ID: 27085624
[TBL] [Abstract][Full Text] [Related]
77. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication.
Hameed A; Sezian N; Thwaini A
Can J Urol; 2007 Dec; 14(6):3745-9. PubMed ID: 18163926
[TBL] [Abstract][Full Text] [Related]
78. Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence.
Ehdaie B; Sylvester R; Herr HW
Eur Urol; 2013 Oct; 64(4):579-85. PubMed ID: 23711538
[TBL] [Abstract][Full Text] [Related]
79. Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer.
Mohammed A; Arastu Z
BMC Urol; 2017 Dec; 17(1):114. PubMed ID: 29212486
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
